NCT05251233 2025-05-06
Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy
Washington University School of Medicine
Phase 2 Terminated
Clinical Trials
9 trialsNCT03948477 2022-05-25
PantoCIN
University of Auckland, New Zealand
Phase 2 Completed
NCT01748500 2021-03-23
Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer
University Health Network, Toronto
Phase 2 Completed
NCT02167633 2021-03-11
Stereocord
Rigshospitalet, Denmark
Phase NA Terminated
NCT01848457 2020-03-16
Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Children's Hospital of Philadelphia
Phase 2 Completed
NCT04217512 2020-01-03
Pantoprazole in Cisplatin Nephrotoxicity
Tanta University
Phase 3 Recruiting
NCT00001191 2017-07-02
The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01163903 2015-07-15
Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours
University Health Network, Toronto
Phase 1 Completed
NCT01179724 2010-08-11
Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial
Samsung Medical Center
Phase NA Unknown